Prolintane

CV disease; moderate to severe hypertension; hyperthyroidism; glaucoma; hyperexcitablity or agitated state; history of drug/alcohol abuse; advanced arteriosclerosis; pregnancy; lactation.

Mild hypertension; impaired kidney function or unstable personality. Monitor child weight and height. Psychoses may be exacerbated. Dependence. Epilepsy. Gradual withdrawal is recommended after prolonged treatment.

Insomnia, night terrors, nervousness, restlessness, irritability, euphoria; fatigue, depression; dry mouth, anorexia, abdominal cramps, headache, dizziness, tremor, sweating, tachycardia, palpitations, hypo- or hypertension, impotence and altered libido. Psychosis, muscle damage and renal complications.

May cause hallucination, psychosis and death.

Increased risk of arrhythmias when used with volatile liquid anaesthetics or TCAs.
Potentially Fatal: Concurrent use with MAOIs or within 14 days of discontinuing MAOI treatment may precipitate hypertensive crisis.

Description:
Mechanism of Action: Prolintane is a mild central stimulant. It acts indirectly as a sympathomimetic.

Thuốc TKTW khác & thuốc trị rối loạn tăng động giảm chú ý